Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data

By sjmartinez • September 27, 2024

Murthy V, Voter AF, Nguyen K, Allen-Auerbach M, Chen L, Caputo S, Ledet E, Akerele A, Tuchayi AM, Lawhn-Heath C, Wang T, Carducci MA, Pomper MG, Paller CJ, Czernin J, Solnes LB, Hope TA, Sartor O, Calais J, Gafita A. Efficacy and Toxicity of [¹⁷⁷Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data. J Nucl Med. 2024 Sep 26:jnumed.124.267816. doi: 10.2967/jnumed.124.267816. Epub ahead of print. PMID: 39327018.

Tags: Cardiology/Epi, EAP, General Internal Medicine, mCRPC, PSMA PET, Publications, vision

Response to “Epicardial fat tissue and diastolic dysfunction in both men and women with HIV”

Goldberg RL, Peterson TE, Haberlen SA, Witt MD, Palella FJ, Magnani JW, Brown TT, Lake JE, Lima JAC, Budoff MJ, Ndumele CE, Wu KC, Post[...]

Comparative analysis of two independent Myh6-Cre transgenic mouse lines

Davenport A, Kessinger CW, Pfeiffer RD, Shah N, Xu R, Abel ED, Tucker NR, Lin Z. Comparative analysis of two independent Myh6-Cre transgenic mouse lines.[...]

BATokines in metabolic liver disease: good cops or bad cops?

Pereira RO, Abel ED. BATokines in metabolic liver disease: good cops or bad cops? EMBO J. 2024 Sep 25. doi: 10.1038/s44318-024-00239-6. Epub ahead of print.[...]